Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Cahn

Showing results (71-80 of 178) with videos related to

Pageof 18
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1983
Intensive cytoreductive regimen and autologous bone marrow transplantation in leukemia. Present status and the future. A reviewP Hervé, T Philip, M Flesch, et al.
Bone Marrow Transplantation|August 24, 1999
Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic LeukemiasJ M Boiron, J Y Cahn, G Meloni, et al.
Cancer Treatment Reports|November 1, 1982
Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remissionP Herve, A Rozenbaum, E Plouvier, et al.
British Journal of Haematology|July 1, 1986
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 casesJ Y Cahn, P Herve, M Flesch, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC)T Philip, R Meckenstock, E Deconnick, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Pageof 18

Showing results (71-80 of 178) with videos related to

Sort By:
Pageof 18
European Journal of Cancer & Clinical Oncology|August 1, 1983
Intensive cytoreductive regimen and autologous bone marrow transplantation in leukemia. Present status and the future. A reviewP Hervé, T Philip, M Flesch, et al.
Bone Marrow Transplantation|August 24, 1999
Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic LeukemiasJ M Boiron, J Y Cahn, G Meloni, et al.
Cancer Treatment Reports|November 1, 1982
Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remissionP Herve, A Rozenbaum, E Plouvier, et al.
British Journal of Haematology|July 1, 1986
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 casesJ Y Cahn, P Herve, M Flesch, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC)T Philip, R Meckenstock, E Deconnick, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six casesA Brion, J Y Cahn, C Mougin, et al.
Pageof 18